111 Capital’s Globus Medical GMED Stock Holding History

111 Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,019	Closed	-$663K	–	515
2024 Q4	$663K	Buy	+8,019	New	+$632K	0.14%	159

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

111 Capital's GMED Position: Q1 2025 in Review

111 Capital sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 8,019 shares — an estimated $663K sold.

111 Capital first reported a position in GMED in Q4 2024 and held it in 1 quarter. The position peaked at $663K in Q4 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

111 Capital reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
111 Capital sold 8,019 Globus Medical shares in Q1 2025, an estimated $663K.
111 Capital first reported a position in Globus Medical in Q4 2024 and held it in 1 quarter.
111 Capital's Globus Medical position peaked at $663K in Q4 2024.
514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on 111 Capital's 13F filing for Q1 2025, filed 15 May 2025.